Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 55 Ovarian Neoplasms 39 Carcinoma, Hepatocellular 39 Neoplasms 25 Fallopian Tube Neoplasms 21 Carcinoma, Non-Small-Cell Lung 20 Endometrial Neoplasms 14 Glioblastoma 11 Breast Neoplasms 11 Brain Neoplasms 11 Colonic Neoplasms 10 Neoplasm Metastasis 9 Lung Neoplasms 8 Liver Neoplasms 8 Uterine Cervical Neoplasms 7 Stomach Neoplasms 6 Rectal Neoplasms 6 Glioma 6 Biliary Tract Neoplasms 6 Carcinoma, Ovarian Epithelial 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Small Cell Lung Carcinoma 3 Sarcoma 3 Recurrence 3 Peritoneal Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms, Nerve Tissue 3 Gastrointestinal Neoplasms 3

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Liver Cancers × Bevacizumab × 90 days × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡